Clinical Impact of Next-Generation Sequencing (NGS) in Blood Liquid Biopsies for Treatment Decisions in Advanced NSCLC

被引：0
|
作者：
Garcia Pardo, M. [1 ]
Martinez Delfrade, I. [1 ]
Aparicio Salcedo, I. [1 ]
Arregui Valles, M. [1 ]
Alva Bianchi, M. [1 ]
Tirado Anula, V. [1 ]
Alvarez, R. [2 ]
Calles Blanco, A. [3 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Med Oncol, Madrid, Spain
[2] Hosp Univ Gregorio Maranon, Dept Med Oncol, Madrid, Spain
[3] Hosp Gen Univ Gregorio Maranon, Oncol, Madrid, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Next-generation sequencing; liquid biopsy; Targeted therapy;
D O I：
10.1016/j.jtho.2019.08.1814
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.14-29
引用
收藏
页码：S840 / S841
页数：2
相关论文
共 50 条
  • [1] Rapid in House Next Generation Sequencing and Impact on Treatment Decisions and Initiation in Advanced NSCLC
    Kang, R. S.
    Bisson, K. M.
    Beharry, A.
    Goonaratne, E.
    Sheffield, B. S.
    Cheema, P.
    Perdrizet, K.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S481 - S482
  • [2] The Impact of Next-Generation Sequencing on Clinical Decisions in Lung Cancer
    Rozenblum, Anna Belilovski
    Ilouze, Maya
    Dudnik, Elizabeth
    Flex, Dov
    Soussan-Gutman, Lior
    Dvir, Addie
    Peled, Nir
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S274 - S274
  • [3] Clinical and Economic Impact of Upfront Next-Generation Sequencing for Metastatic NSCLC in East Asia
    Loong, Herbert H.
    Wong, Carlos K. H.
    Chan, Catherine P. K.
    Chang, Andrea
    Zhou, Zheng-Yi
    Tang, Wenxi
    Gibbs, Meaghan
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (03):
  • [4] Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients With Advanced, Treatment-Naïve NSCLC
    Bote-de Cabo, Helena
    Siringo, Marco
    Conde, Esther
    Hernandez, Susana
    Lopez-Rios, Fernando
    Castelo-Loureiro, Alicia
    Garcia-Lorenzo, Esther
    Baena, Javier
    Herrera, Mercedes
    Enguita, Ana Belen
    Ruano, Yolanda
    Zugazagoitia, Jon
    Paz-Ares, Luis
    JTO CLINICAL AND RESEARCH REPORTS, 2025, 6 (03):
  • [5] Clinical Impact of Hybrid Capture-Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer
    Rozenblum, Anna Belilovski
    Ilouze, Maya
    Dudnik, Elizabeth
    Dvir, Addie
    Soussan-Gutman, Lior
    Geva, Smadar
    Peled, Nir
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (02) : 258 - 268
  • [6] Impact of Next-Generation Sequencing (NGS) technology on cardiovascular disease research
    Xu, Fengping
    Wang, Qin
    Zhang, Fangfang
    Zhu, Yinling
    Gu, Qingquan
    Wu, Liping
    Yang, Lin
    Yang, Xu
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2012, 2 (02) : 138 - 146
  • [7] Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis
    van Amerongen, Rosa A.
    Retel, Valesca P.
    Coupe, Veerle M. H.
    Nederlof, Petra M.
    Vogel, Maartje J.
    van Harten, Wim H.
    ECANCERMEDICALSCIENCE, 2016, 10
  • [8] Next-Generation Sequencing with Liquid Biopsies from Treatment-Naive Non-Small Cell Lung Carcinoma Patients
    Hofman, Paul
    CANCERS, 2021, 13 (09)
  • [9] Power and Promise of Next-Generation Sequencing in Liquid Biopsies and Cancer Control
    Wu, Ting-Miao
    Liu, Ji-Bin
    Liu, Yu
    Shi, Yi
    Li, Wen
    Wang, Gao-Ren
    Ma, Yu-Shui
    Fu, Da
    CANCER CONTROL, 2020, 27 (03)
  • [10] Next-generation sequencing for tumor mutation quantification using liquid biopsies
    Provencio, Mariano
    Perez-Barrios, Clara
    Barquin, Miguel
    Calvo, Virginia
    Franco, Fabio
    Sanchez, Estela
    Sanchez, Ricardo
    Marsden, Daniel
    Cristobal Sanchez, Juan
    Martin Acosta, Paloma
    Laza-Briviesca, Raquel
    Cruz-Bermudez, Alberto
    Romero, Atocha
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (02) : 306 - 313
12345